Oral Cancer Institute

Human Papillomavirus (HPV) is increasingly recognized as a significant risk factor for oropharyngeal cancers, leading to a rise in HPV-positive cases among younger, non-smoking patients. These cancers often have a better prognosis compared to traditional tobacco-related throat cancers.

Understanding the impact of HPV is essential for both medical providers and the public, highlighting the importance of early detection and vaccination.

Stay informed and proactive in cancer prevention and patient care. Call 📞 773-245-5253 for more information.

https://oralcancer.com/oro-pharyngeal-cancer/

The parotid gland is the most common site for salivary gland tumors, accounting for ~80% of cases. Key features include:

🔴 Frequency: 75-80% of parotid gland tumors are benign, most commonly pleomorphic adenomas. Malignant types include mucoepidermoid carcinoma and adenoid cystic carcinoma.
🔴 Presentation: Typically present as painless, slow-growing masses near the ear. Facial nerve involvement, such as weakness or paralysis, raises suspicion of malignancy.
🔴 Surgical Complexity: Surgery involves intricate dissection to preserve the facial nerve, underscoring the importance of head and neck oncology expertise.

Parotid gland tumors demand precise diagnosis and management to ensure optimal outcomes.

☎️ For advanced care and expert consultation, contact us at 773-245-5253.